retatrutide fda approval status november 2025 Retatrutide, an experimental weight-loss drug, has not been approved by the FDA. But, doctors and nurse practitioners in clinics across the country are prescribing it anyway, a CBS News investigation Will the FDA approve retatrutide?

The current $1,000+ monthly price tags are out of reach for most Americans, and theyre fueling the rise of gray market alternatives

Microdose semaglutide is $179 and microdose tirzepatide is $269 for a 28-day supply, with async care-team messaging included rather than billed separately.

Understanding GLP-1 Medications To appreciate the importance of vitamins while on GLP-1 medications, its essential to understand how these drugs work

Readers wanting what's brand-stated, what research supports, and what to confirm before ordering - keep reading

For reference on what standard titration looks like, the starting dose of tirzepatide guide covers what patients typically experience in the early weeks